Research article · 2017
Conference abstractPublished 8 Jun 2018
Same and different: Version 4 of the eCTD standard
ACUTA, LLC, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The electronic common technical document standard, established in 2003, has been a boon for both regulators and drug sponsors, as it speeds review and provides a consistent framework for market, and investigational trial authorization. It has been implemented in the US, the European Union, Switzerland, South Africa, the Gulf Coast Consortium, and is accepted in many other countries as the primary electronic review medium. Version 4 of the standard is a radical change to the packaging of the authorization dossiersâÂ?Â?but with no change to the actual content. Its benefits include greater flexibility to support more submission and product types, but will require updates to software. With FDA about to accept version 4 in a pilot program, it is critical to learn how this will affect your company. This session will explore the technical issues that will make implementation difficult, but also the similarities that make regulatory’s job nearly unchanged.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 28 Jun 2023
The Mechanisms of Vaccination: Exploring Different Formulations by the Central Drugs Standard Control Organization (CDSCO)
Short communication · 30 Apr 2020
Quality Control Standardization and Comparative Anthelmintic Activity of Different Extracts from Evolvulus alsinoides L
Research article · 3 May 2019
Comparative standardization and physicochemical evaluation of the fruits of Tribulus terrestris L. from different seasonal and geographical sources
Research article · 18 Nov 2016
PHYSICO CHEMICAL STANDARDIZATION OF DIFFERENT SAMPLES OF SUVARNAMAKSHIK (CHALCOPYRITE)
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joel Finkle”

